269 related articles for article (PubMed ID: 20957039)
1. PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma.
Bachetti T; Di Paolo D; Di Lascio S; Mirisola V; Brignole C; Bellotti M; Caffa I; Ferraris C; Fiore M; Fornasari D; Chiarle R; Borghini S; Pfeffer U; Ponzoni M; Ceccherini I; Perri P
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957039
[TBL] [Abstract][Full Text] [Related]
2. miR-204 mediates post-transcriptional down-regulation of PHOX2B gene expression in neuroblastoma cells.
Bachetti T; Di Zanni E; Ravazzolo R; Ceccherini I
Biochim Biophys Acta; 2015 Aug; 1849(8):1057-65. PubMed ID: 26145533
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells.
Di Zanni E; Fornasari D; Ravazzolo R; Ceccherini I; Bachetti T
Exp Cell Res; 2015 Aug; 336(1):43-57. PubMed ID: 25882494
[TBL] [Abstract][Full Text] [Related]
4. PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma.
Longo L; Borghini S; Schena F; Parodi S; Albino D; Bachetti T; Da Prato L; Truini M; Gambini C; Tonini GP; Ceccherini I; Perri P
Int J Oncol; 2008 Nov; 33(5):985-91. PubMed ID: 18949361
[TBL] [Abstract][Full Text] [Related]
5. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
[TBL] [Abstract][Full Text] [Related]
6. New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.
Di Paolo D; Yang D; Pastorino F; Emionite L; Cilli M; Daga A; Destafanis E; Di Fiore A; Piaggio F; Brignole C; Xu X; Liang C; Gibbons J; Ponzoni M; Perri P
Oncotarget; 2015 Oct; 6(30):28774-89. PubMed ID: 26299615
[TBL] [Abstract][Full Text] [Related]
7. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
8. PHOX2A and PHOX2B are differentially regulated during retinoic acid-driven differentiation of SK-N-BE(2)C neuroblastoma cell line.
Di Lascio S; Saba E; Belperio D; Raimondi A; Lucchetti H; Fornasari D; Benfante R
Exp Cell Res; 2016 Mar; 342(1):62-71. PubMed ID: 26902400
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma.
Trochet D; Bourdeaut F; Janoueix-Lerosey I; Deville A; de Pontual L; Schleiermacher G; Coze C; Philip N; Frébourg T; Munnich A; Lyonnet S; Delattre O; Amiel J
Am J Hum Genet; 2004 Apr; 74(4):761-4. PubMed ID: 15024693
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of the 5' upstream promoter of the human Phox2a gene: possible direct transactivation by transcription factor Phox2b.
Hong SJ; Kim CH; Kim KS
J Neurochem; 2001 Dec; 79(6):1225-36. PubMed ID: 11752063
[TBL] [Abstract][Full Text] [Related]
11. Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma.
Di Paolo D; Ambrogio C; Pastorino F; Brignole C; Martinengo C; Carosio R; Loi M; Pagnan G; Emionite L; Cilli M; Ribatti D; Allen TM; Chiarle R; Ponzoni M; Perri P
Mol Ther; 2011 Dec; 19(12):2201-12. PubMed ID: 21829174
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma.
Raabe EH; Laudenslager M; Winter C; Wasserman N; Cole K; LaQuaglia M; Maris DJ; Mosse YP; Maris JM
Oncogene; 2008 Jan; 27(4):469-76. PubMed ID: 17637745
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons.
Reiff T; Tsarovina K; Majdazari A; Schmidt M; del Pino I; Rohrer H
J Neurosci; 2010 Jan; 30(3):905-15. PubMed ID: 20089899
[TBL] [Abstract][Full Text] [Related]
14. ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation.
Borenäs M; Umapathy G; Lai WY; Lind DE; Witek B; Guan J; Mendoza-Garcia P; Masudi T; Claeys A; Chuang TP; El Wakil A; Arefin B; Fransson S; Koster J; Johansson M; Gaarder J; Van den Eynden J; Hallberg B; Palmer RH
EMBO J; 2021 Feb; 40(3):e105784. PubMed ID: 33411331
[TBL] [Abstract][Full Text] [Related]
15. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
16. PHOX2B analysis in non-syndromic neuroblastoma cases shows novel mutations and genotype-phenotype associations.
McConville C; Reid S; Baskcomb L; Douglas J; Rahman N
Am J Med Genet A; 2006 Jun; 140(12):1297-301. PubMed ID: 16691592
[TBL] [Abstract][Full Text] [Related]
17. The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line.
Yi B; Yang J; Wang L
Tumour Biol; 2014 Apr; 35(4):3229-35. PubMed ID: 24293393
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of N-linked glycosylation impairs ALK phosphorylation and disrupts pro-survival signaling in neuroblastoma cell lines.
Del Grosso F; De Mariano M; Passoni L; Luksch R; Tonini GP; Longo L
BMC Cancer; 2011 Dec; 11():525. PubMed ID: 22192458
[TBL] [Abstract][Full Text] [Related]
19. Identification of ALK as a major familial neuroblastoma predisposition gene.
Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.
Di Paolo D; Brignole C; Pastorino F; Carosio R; Zorzoli A; Rossi M; Loi M; Pagnan G; Emionite L; Cilli M; Bruno S; Chiarle R; Allen TM; Ponzoni M; Perri P
Mol Ther; 2011 Jun; 19(6):1131-40. PubMed ID: 21487394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
